IVF denied as experimental or investigational by Aetna?

Aetna's specific coverage criteria for IVF are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Aetna Denied IVF as Experimental

An experimental or investigational denial for in vitro fertilization from Aetna can arise in two distinct situations: (1) IVF itself is being denied as a covered benefit under this framing, often for a plan that broadly excludes infertility treatment; or (2) a specific IVF-associated procedure, protocol, or add-on — such as preimplantation genetic testing, a particular stimulation protocol, or an adjunct intervention — has been flagged as experimental even while standard IVF is covered.

Understanding which scenario applies is the first step, because the appeal strategy differs. Standard IVF supported by decades of clinical evidence is rarely upheld as experimental by an IRO. Novel adjuncts with limited published evidence face a harder path.

## Federal Appeal Framework

• ACA §2719 / ERISA §503: You are entitled to a full internal appeal with a written explanation of the exact clinical evidence standard Aetna applied and which component of IVF it considers experimental.
• State infertility mandates: Depending on your state and plan type, state law may require coverage of IVF. Confirm whether your state has an infertility coverage mandate and whether your plan is subject to it (fully insured plans are; self-funded ERISA plans generally are not).
• External review: If the internal appeal is denied, you may escalate to an IRO. Under ACA rules, experimental/investigational denials receive IRO review applying recognized clinical standards — not just the plan's internal policy. You generally have approximately four months from the denial date to file; confirm the exact deadline from the denial letter.
• Expedited option: Reproductive medicine involves time-sensitive biological factors; document any clinical urgency (for example, declining ovarian reserve) when requesting expedited review.

## Concrete Appeal Process and Timeline

1. Request the full denial reasoning from Aetna in writing — specifically, which procedure or component is deemed experimental and which clinical-evidence standard was applied. 2. Have the treating reproductive endocrinologist identify the relevant professional society guidelines (such as ASRM — American Society for Reproductive Medicine) supporting the procedure. 3. File a written internal appeal within Aetna's stated deadline (typically 180 days from the denial) with the full clinical package. 4. Aetna must respond within 30 days (prospective) or 60 days (retrospective). 5. If denied internally, file for IRO external review before the four-month external-review window closes.

## Documentation to Gather

• Diagnosis confirmation: Records from the treating reproductive endocrinologist documenting the diagnosis of infertility or the specific underlying condition, and the clinical basis for recommending IVF.
• Guideline support: The applicable ASRM practice committee opinion or other recognized reproductive medicine society guideline supporting the recommended procedure. Obtain the current published version.
• Evidence summary: Your prescriber may include in the medical-necessity letter a summary of the published evidence supporting the procedure — not citing specific trial names or statistics, but noting that it is considered established practice by the relevant professional society.
• Clinical necessity per the chart: Office notes documenting why IVF (or the specific procedure at issue) is the appropriate intervention for this patient, including prior treatment history and outcomes.
• Prescriber medical-necessity letter: A structured letter from the reproductive endocrinologist that addresses each of Aetna's experimental-denial criteria directly, cites the relevant ASRM guidelines, and maps the patient's clinical situation to the established evidence base.

## Criteria-Mapping Structure

Obtain Aetna's clinical policy bulletin for IVF and its definition of experimental/investigational. Map your evidence to each criterion:

| Experimental-Denial Criterion | Evidence | |---|---| | Procedure lacks adequate published evidence | [ASRM guideline or practice opinion supporting the procedure] | | Procedure is not standard of care for the indication | [Prescriber documentation that this is the recognized standard for this clinical scenario] | | Approval by relevant regulatory or professional body | [Reference to professional society endorsement of the procedure] |

Attach all referenced records and guideline documents. IROs reviewing experimental denials for procedures endorsed by major professional societies consistently apply objective standards that favor established clinical practice over restrictive plan language.